Your browser doesn't support javascript.
loading
Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results.
Pidala, Joseph; Walton, Kelly; Elmariah, Hany; Kim, Jongphil; Mishra, Asmita; Bejanyan, Nelli; Nishihori, Taiga; Khimani, Farhad; Perez, Lia; Faramand, Rawan G; Davila, Marco L; Nieder, Michael L; Sagatys, Elizabeth M; Holtan, Shernan G; Lawrence, Nicholas J; Lawrence, Harshani R; Blazar, Bruce R; Anasetti, Claudio; Sebti, Said M; Betts, Brian C.
Affiliation
  • Pidala J; Department of Blood and Marrow Transplantation - Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Walton K; Department of Immunology, Moffitt Cancer Center, Tampa, Florida.
  • Elmariah H; Department of Oncologic Sciences, University of South Florida, Tampa, Florida.
  • Kim J; Division of Hematology, Oncology, and Transplantation, Department of Medicine, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
  • Mishra A; Department of Blood and Marrow Transplantation - Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Bejanyan N; Department of Oncologic Sciences, University of South Florida, Tampa, Florida.
  • Nishihori T; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida.
  • Khimani F; Department of Blood and Marrow Transplantation - Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Perez L; Department of Oncologic Sciences, University of South Florida, Tampa, Florida.
  • Faramand RG; Department of Blood and Marrow Transplantation - Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Davila ML; Department of Oncologic Sciences, University of South Florida, Tampa, Florida.
  • Nieder ML; Department of Blood and Marrow Transplantation - Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Sagatys EM; Department of Oncologic Sciences, University of South Florida, Tampa, Florida.
  • Holtan SG; Department of Blood and Marrow Transplantation - Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Lawrence NJ; Department of Oncologic Sciences, University of South Florida, Tampa, Florida.
  • Lawrence HR; Department of Blood and Marrow Transplantation - Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Blazar BR; Department of Oncologic Sciences, University of South Florida, Tampa, Florida.
  • Anasetti C; Department of Blood and Marrow Transplantation - Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Sebti SM; Department of Oncologic Sciences, University of South Florida, Tampa, Florida.
  • Betts BC; Department of Blood and Marrow Transplantation - Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
Clin Cancer Res ; 27(10): 2712-2722, 2021 05 15.
Article in En | MEDLINE | ID: mdl-33753457
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Bridged-Ring Compounds / Tacrolimus / Hematopoietic Stem Cell Transplantation / Janus Kinase Inhibitors / Graft vs Host Disease / Immunosuppressive Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2021 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Bridged-Ring Compounds / Tacrolimus / Hematopoietic Stem Cell Transplantation / Janus Kinase Inhibitors / Graft vs Host Disease / Immunosuppressive Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2021 Document type: Article Country of publication: United States